Analyst Ratings for Akari Therapeutics (AKTX)

AKTX Rating Summary

AKTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AKTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $1.30 (-88.4%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 79%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/8/2026 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 3.80
(11.20)		 194.74% Details
1/5/2026 Ladenburg Thalmann Aydi New Coverage Buy
(N/A)		 1.00
(N/A)		 0.29
(11.20)		 3762.07% Details